Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events
Open Access
- 2 April 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 20 (7) , 791-797
Abstract
In the nontransplant setting, aberrant serum adipokine levels are associated with cardiovascular (CV) disease. The effects of liver transplantation (LT) on serum adipokine levels and their association with post-LT CV disease have not been studied. A nested case-control study of 77 patients with major CV events more than 4 months after LT analyzed serum adiponectin, resistin, leptin, C-reactive protein, and apolipoprotein levels measured before transplantation and 4, 12, and 24 months after LT. Adiponectin and resistin levels decreased dramatically after LT in all patients. Recipients with CV disease had lower levels of adiponectin and higher levels of resistin, leptin, C-reactive protein, and apolipoprotein B100 than controls. The pre-LT adiponectin level was associated with a 16% increased risk for CV events for every 1 μg/mL decrease in adiponectin [hazard ratio (HR) = 0.84, P = 0.046]. Pre-LT C-reactive protein levels (HR = 1.03, P = 0.047) and 12-month C-reactive protein levels (HR = 1.03, P = 0.03) were associated with CV events after LT. Pre-LT Diabetes (HR = 2.14, P = 0.09), and post-LT resistin (HR = 1.07, P = 0.07), and apolipoprotein B (HR = 1.08, P = 0.08) were associated with a nonsignificantly increased risk of CV events in this small sample size. In conclusion, pre- and post-LT changes in serum adipokine and inflammatory markers may be signals of an increased risk of CV events after LT, but further study is needed. Liver Transpl 20:791–797, 2014. © 2014 AASLD.Keywords
Funding Information
- National Center for Research Resources (1 UL1 RR024150)
This publication has 28 references indexed in Scilit:
- Liver fibrogenesis and metabolic factorsClinics and Research in Hepatology and Gastroenterology, 2011
- Predictors of cardiovascular events after liver transplantationLiver Transplantation, 2011
- Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up StudyAmerican Journal of Transplantation, 2010
- Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: single-center cross-sectional analysisTransplant International, 2009
- Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular eventsLiver Transplantation, 2007
- Interplay Between Systemic Inflammation and Markers of Insulin Resistance in Cardiovascular Prognosis After Heart TransplantationThe Journal of Heart and Lung Transplantation, 2007
- Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in MenCirculation, 2005
- Adipokines: molecular links between obesity and atheroslcerosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamicsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004